Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Azithromycin MDA in Côte d'Ivoire
NCT05016895Completed
- Sponsor
- FHI 360
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in child mortality (U5MR), sponsored by FHI 360. Primary endpoints: % of eligible population covered by intervention at 3 years, Infant mortality rate at 3 years and 1 more. Started Aug 2021; status: completed.
02
Drugs
azithromycin
03
Conditions
child mortality (U5MR)
Beyond the preview
Go deeper on NCT05016895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016895.